Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Modi-1 |
| Synonyms | |
| Therapy Description |
Modi-1 is a peptide vaccine comprised of two citrullinated vimentin peptides and a citrullinated enolase peptide, which may result in the induction of an antitumor immune response (PMID: 32561639). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Modi-1 | Modi 1|Modi1 | Modi-1 is a peptide vaccine comprised of two citrullinated vimentin peptides and a citrullinated enolase peptide, which may result in the induction of an antitumor immune response (PMID: 32561639). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05329532 | Phase Ib/II | Modi-1 Modi-1 + Pembrolizumab | Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer (ModiFY) | Recruiting | GBR | 0 |